The Swiss 3D printing specialist Exentis Group AG has made a successful start to 2025. Two further 3D production systems have been delivered since the start of the year. These are used in the new energy sector and are used for the industrial production of components for fuel cells.
Exentis was able to acquire new customers in the USA in particular. Following the delivery of nine production systems in the fourth quarter of 2024, the company has received further major orders. The new customers include two well-known US companies listed on the Dow Jones index.
In addition to the industrial sector, Exentis is also expanding its activities in the pharmaceutical industry. In the next step, two 3D production systems will be delivered to the license partner Laxxon Medical. One of these systems will go to Laxxon’s German development site, while another, larger production system will be delivered to a customer in Ohio, USA.
The company plans to publish its 2024 annual report in the second quarter of 2025.
Subscribe to our Newsletter
3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
